Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment
Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 2/11/2025 | $51.00 | Buy | Jefferies | |
| 2/11/2025 | $48.00 | Hold → Buy | CFRA | |
| 1/31/2025 | $200.00 | Underweight | KeyBanc Capital Markets | |
| 1/29/2025 | Outperform → Perform | Oppenheimer | ||
| 1/28/2025 | Buy | TD Cowen | ||
| 1/27/2025 | $260.00 → $280.00 | Outperform | Wedbush | |
| 1/24/2025 | $256.00 → $253.00 | Buy | BofA Securities | |
| 1/23/2025 | $286.00 → $280.00 | Buy | Goldman |
After launching the powerful eero Max 7 and the tough eero Outdoor 7, eero expands Wi-Fi 7 portfolio with all-new eero 7 and eero Pro 7 eero 7 is the company's most affordable Wi-Fi 7 router, offering multi-gigabit speeds in a compact form factor eero Pro 7 delivers premium Wi-Fi 7 performance for high-bandwidth connectivity needs, offering fast wireless and wired speeds with two 5 GbE ports, and capacity for hundreds of devices Amazon (NASDAQ:AMZN) announced that eero is expanding its Wi-Fi 7 portfolio to include eero 7, delivering multi-gigabit speeds at a more affordable price, and eero Pro 7, offering premium performance for bandwidth-demanding networks. Thanks to the company's TrueM
ATHENS, Ga., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Terrapin Beer Co., a Tilray Beverages craft beer brand under Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), is excited to announce the 20th anniversary of its Wake-n-Bake Coffee Oatmeal Imperial Stout seasonal beer and the annual Wake-n-Bake Off event on Sunday, January 26th, 2025, at the Terrapin taproom in Athens, GA. In celebration of its 20th anniversary, guests will have the chance to observe local restaurants competing to craft the finest dish featuring Terrapin's renowned Wake-n-Bake Beer. This event highlights culinary innovation and fosters community engagement through an array of sweet and savory tastings that showcase the rich flavor
Founder Col Needham Becomes Executive Chair, Nikki Santoro Named CEO, Positioning IMDb for Next Phase of Innovation and Growth IMDb (www.imdb.com), the world's most popular and authoritative source for information on movies, TV shows, and celebrities, today announced that Founder & Chief Executive Officer Col Needham has transitioned to the role of Founder & Executive Chair. Nikki Santoro, who has served as IMDb Chief Operating Officer since 2021, has been appointed the Chief Executive Officer of IMDb. This marks a significant milestone in the company's 35-year history, with Santoro becoming only the second CEO and the first woman to hold the role. This press release features multimedia.
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Waystar Holding Corp. (0001990354) (Issuer)
4 - Super Micro Computer, Inc. (0001375365) (Issuer)
Jefferies initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $51.00
CFRA upgraded Super Micro Computer from Hold to Buy and set a new price target of $48.00
KeyBanc Capital Markets reiterated coverage of Apple with a rating of Underweight and set a new price target of $200.00
424B7 - Waystar Holding Corp. (0001990354) (Filer)
8-K - Super Micro Computer, Inc. (0001375365) (Filer)
6-K - Tiziana Life Sciences Ltd (0001723069) (Filer)
Fiscal year 2024 revenue of $944M, up 19% YoY Q4 revenue growth of 18% year-over-year Q4 net income of $19.1 million and non-GAAP net income of $52.1 million Fiscal year 2024 net loss $19.1 million, 62.7% improvement YoY Fiscal year 2024 adjusted EBITDA of $383M, up 15% YoY Q4 net income margin of 8%; adjusted EBITDA margin of 41% LEHI, Utah and LOUISVILLE, Ky., Feb. 18, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the fourth quarter and full year ended December 31, 2024. "We are please
Super Micro Computer, Inc. (NASDAQ:SMCI) ("Supermicro" or the "Company"), a Total IT Solution Provider for AI, Cloud, Storage, and 5G/Edge, today announced preliminary financial information for its second quarter of fiscal year 2025 ended December 31, 2024. Preliminary Second Quarter Fiscal Year 2025 Highlights The Company expects to report the following financial information for the quarter ended December 31, 2024: Net sales in the range of $5.6 billion to $5.7 billion, reflecting 54% year-over-year growth at the midpoint GAAP and non-GAAP gross margin in the range of 11.8% to 11.9% GAAP diluted net income per common share in the range of $0.50 to $0.52, flat year-over-year
PALO ALTO, Calif., Feb. 6, 2025 /PRNewswire/ -- Broadcom Inc. (NASDAQ:AVGO), a global technology leader that designs, develops and supplies semiconductor and infrastructure software solutions, today announced it will report its first quarter fiscal year 2025 financial results and business outlook on Thursday, March 6, 2025 after the close of the market. Broadcom's management will host a conference call at 2:00 p.m. Pacific Time on the same day to discuss these results and business outlook. Date: Thursday, March 6, 2025 Time: 2:00 PM (PT); 5:00 PM (ET) Listen via Internet: The conference call can be accessed live online in the Investors section of the Broadcom website at https://investors.br
4 - C3.ai, Inc. (0001577526) (Issuer)
4 - AMAZON COM INC (0001018724) (Issuer)
4 - AMAZON COM INC (0001018724) (Issuer)
NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced a product development services agreement with Renaissance Lakewood LLC ("Renaissance"), a leading Contract Development and Manufacturing Organization (CDMO) focused on nasal drug delivery. This collaboration aims to optimize the current formulation and develop a comprehensive plan for the scale-up of foralumab in a nasal device. Intranasal foralumab is currently under development for
LEHI, UT. and LOUISVILLE, KY., Feb. 20, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY) ("Waystar"), a provider of leading healthcare payments software, today announced the pricing of its underwritten public offering of 20,000,000 shares of its common stock by certain investment funds of EQT AB and Bain Capital, LP, and Canada Pension Plan Investment Board (CPP Investments), and their respective affiliates (collectively, the "Selling Stockholders") at a price to the public of $40.00 per share. Additionally, the Selling Stockholders have granted the underwriters a 30-day option to purchase up to 3,000,000 additional shares of common stock. Waystar is not selling any shares and will no
adidas.com and adidas app customers will soon enjoy the power of Amazon's fulfillment network and the trust and recognition of Prime Buy with Prime will enhance the sportswear brand's online shopping experience through fast, free delivery, easy returns, and 24/7 shopper support Prime members shopping on adidas.com and the adidas app can enjoy the familiar Prime shopping benefits they know and love starting Spring 2025 Amazon (NASDAQ:AMZN) today announced the expansion of its Buy with Prime service, a direct-to-customer (DTC) offering, to soon include adidas.com and the adidas app. For millions of U.S.-based Prime members, Buy with Prime is a benefit that unlocks even greater selection of
SC 13G - Waystar Holding Corp. (0001990354) (Subject)
SC 13G/A - C3.ai, Inc. (0001577526) (Subject)
SC 13G - Super Micro Computer, Inc. (0001375365) (Subject)
For Immediate Release: September 17, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued a draft guidance, “Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice,” which, when finalized, will support the conduct of randomized controlled trials with streamlined protocols a
For Immediate Release: September 12, 2024 Today, the U.S. Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature, intended to be used with compatible versions of the Apple AirPods Pro headphones. Once installed and customized to the user’s hearing needs, the Hearing Aid Feature enables compatible versions of the AirPods Pro to serve as an OTC hea
For Immediate Release: November 14, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA updated the advisory for the Investigation of Elevated Lead Levels in Cinnamon Applesauce Pouches to include an expanded recall from WanaBana LLC to include Weis and Schnucks-brand cinnamon applesauce pouches. As of November 13, 2023, there
